TrialThe Lancet. Respiratory medicine2017

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study.

John H Beigel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.